Genenta Science S.p.A. (GNTA): Cash & Equivalents

Annual figures by period end, from SEC filings.

5.53M EUR
As of 2025-12-31
-43.0%
3-year compound annual growth
-18.6%
5-year compound annual growth
37.24M EUR2020-12-31: 15.47M EUR2021-12-31: 37.24M EUR2022-12-31: 29.79M EUR2023-12-31: 3.69M EUR2024-12-31: 4.58M EUR2025-12-31: 5.53M EUR5.53M EUR
2020-12-31 Cash & Equivalents (EUR) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-315.53M EUR+20.6%2026-04-01, Balance as of period end
2024-12-314.58M EUR+24.1%2026-04-01, Balance as of period end
2023-12-313.69M EUR-87.6%2026-04-01, Balance as of period end
2022-12-3129.79M EUR-20.0%2025-03-28, Balance as of period end
2021-12-3137.24M EUR+140.8%2024-03-29, Balance as of period end
2020-12-3115.47M EURn/a2022-05-02, Balance as of period end